US Patent 9522129 Pharmaceutical Combination
Patent 9522129 was granted and assigned to Velicept Therapeutics on December, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9522129 Pharmaceutical Combination
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
